GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Protect Pharmaceutical Corp (OTCPK:PRTT) » Definitions » EV-to-FCF

Protect Pharmaceutical (Protect Pharmaceutical) EV-to-FCF : (As of May. 16, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Protect Pharmaceutical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Protect Pharmaceutical's Enterprise Value is $3.03 Mil. Protect Pharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2018 was $0.00 Mil. Therefore, Protect Pharmaceutical's EV-to-FCF for today is .

The historical rank and industry rank for Protect Pharmaceutical's EV-to-FCF or its related term are showing as below:

PRTT's EV-to-FCF is not ranked *
in the Conglomerates industry.
Industry Median: 15.41
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Protect Pharmaceutical's stock price is $2.675. Protect Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.010. Therefore, Protect Pharmaceutical's PE Ratio for today is At Loss.


Protect Pharmaceutical EV-to-FCF Historical Data

The historical data trend for Protect Pharmaceutical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protect Pharmaceutical EV-to-FCF Chart

Protect Pharmaceutical Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only - - -37.05 -79.39 -

Protect Pharmaceutical Quarterly Data
Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Protect Pharmaceutical's EV-to-FCF

For the Conglomerates subindustry, Protect Pharmaceutical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Protect Pharmaceutical's EV-to-FCF Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Protect Pharmaceutical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-FCF falls into.



Protect Pharmaceutical EV-to-FCF Calculation

Protect Pharmaceutical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3.026/0
=

Protect Pharmaceutical's current Enterprise Value is $3.03 Mil.
Protect Pharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Protect Pharmaceutical  (OTCPK:PRTT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Protect Pharmaceutical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.675/-0.010
=At Loss

Protect Pharmaceutical's share price for today is $2.675.
Protect Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Protect Pharmaceutical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Protect Pharmaceutical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Protect Pharmaceutical (Protect Pharmaceutical) Business Description

Traded in Other Exchanges
N/A
Address
12465 South Street, Suite 240, Draper, UT, USA, 84020
Protect Pharmaceutical Corp has an organic solution to soil and crop protection, annual growth, and natural restoration upon the completion of crop cycles. The company uses its products to revitalize farming soil, produce organic, toxin-free crops, and meet the increasing global demand for agricultural sustainability initiatives.